We observed that CA1a tumours had more localisation of CD63 and ITGAV than MB‐231 tumours (Figure 5d), supporting our finding that increased ITGAV was exported into the cancer‐derived EVs in metastatic tumours in vivo. The gene discussed is CD63; the disease is cancer.